- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
9
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
9 companies
Johnson & Johnson
Market Cap: US$497.2b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$206.37
7D
-3.6%
1Y
42.1%
Merck
Market Cap: US$250.9b
Operates as a healthcare company worldwide.
MRK
US$101.09
7D
0.8%
1Y
1.7%
Exelixis
Market Cap: US$11.9b
An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.
EXEL
US$44.30
7D
7.1%
1Y
32.3%
ADMA Biologics
Market Cap: US$4.7b
A biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally.
ADMA
US$19.58
7D
-0.8%
1Y
10.5%
CorMedix
Market Cap: US$947.0m
A biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States.
CRMD
US$12.02
7D
6.1%
1Y
42.8%
SIGA Technologies
Market Cap: US$449.0m
A commercial-stage pharmaceutical company, focuses on the health security market in the United States.
SIGA
US$6.27
7D
-0.8%
1Y
5.6%
Puma Biotechnology
Market Cap: US$283.7m
A biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally.
PBYI
US$5.63
7D
-3.3%
1Y
100.4%
Abeona Therapeutics
Market Cap: US$276.9m
A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.
ABEO
US$5.11
7D
0.6%
1Y
-10.2%
BioStem Technologies
Market Cap: US$71.0m
A life sciences corporation, focuses on discovering, developing, and producing pharmaceutical and regenerative medicine products and services.
BSEM
US$4.24
7D
7.3%
1Y
-68.7%